Boule Diagnostics is a Swedish company that develops, manufactures and markets consumable products for blood diagnostics, specialising in blood cell counting (CBC) systems. It is a global company with a market presence via distributors and its own organisation in more than 100 countries.
We note a number of risk factors for Boule Diagnostics, including market risk, competition, legal and regulatory risk, product development risk, and currency and macroeconomic risk.